Insmed officer proposes sale of $14.7M in shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
INSMED Inc officer Stacey Nicole Schaeffer Orlov reported a proposed sale of 101,100 common shares, with an aggregate market value of $14,684,816. The notice gives an approximate sale date of November 19, 2026. It lists the shares as acquired through stock plan activity on November 19, 2026, and gives May 11, 2026, as the Rule 10b5-1 plan adoption date.
Key Figures
Key Terms
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What dates does INSM's Form 144 give for the sale and Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.